Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 15, 2022
Patent Application Number
16761964
Date Filed
October 31, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
The present disclosure relates to methods comprising administering compounds that inhibit VISTA and PD-1 (e.g., PD-1, PD-L1, or PD-L2) pathways with a compound that inhibits TIM-3 and PD-1 (e.g., PD-1, PD-L1, or PD-L2) pathways. The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by VISTA, TIM-3, PD-1, PD-L1, and/or PD-L2.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
